Ran Nussbaum - Profile and Investment Details

Investor Profile

Ran Nussbaum is a Venture Capital, Founder, Private Equity Firm, Investor based in Israel with a diverse investment portfolio that includes companies such as Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb, Otic Pharma, Vico Therapeutics, EloxxSilverback Therapeutics, Arno Therapeutics, ArQule, Prevail Therapeutics, Precirix, ARTSaVIT, Nutrinia, Stimatix GI, Stargazer Pharmaceuticals, Adicet Bio, Ocon Healthcare, Abcuro, Horama, Sweetch, StrideBio, Aposense, TargEDys, Neogene Therapeutics, Entera Bio, Raziel Health, Avraham Pharmaceuticals, EyeYon, Step Pharma, Check-Cap, HeadSense Medical, ABAC Therapeutics, Applied Immune Technologies, Metabomed, LogicBio Therapeutics, CritiSense, Collplant, Keros Therapeutics, Eyevensys, Alizé Pharma, MacroCure, cCAM Biotherapeutics, Fore Biotherapeutics, UroGen Pharma, Tisbury Pharmaceuticals, V-Wave, 89bio, Mereo Biopharma, Dynacure, AgomAb Therapeutics, Pi Therapeutics, . Over time, Ran Nussbaum has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ran Nussbaum is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Life Science, Information Technology (IT), Manufacturing, Biotechnology, Health and Hospital Services, Travel, Medical, Therapeutics, Media and Entertainment, Pharmaceuticals may find it worthwhile to explore potential connections with Ran Nussbaum, as their portfolio suggests a familiarity and interest in this area.

Understanding Ran Nussbaum’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.